8-KOther Events

PFIZER INC 8-K Report (Apr 20, 2004)

Filed April 20, 2004For Securities:PFE

Summary

This 8-K filing from Pfizer Inc. (PFE), dated April 20, 2004, announces the company's financial results for the first quarter of 2004. The report primarily serves to furnish a press release detailing these results, which is included as an exhibit. Investors should review the press release for specific performance metrics, revenue figures, and any commentary from management on the company's operational and financial condition during the quarter. The core of this filing is the Q1 2004 earnings announcement. While the 8-K itself is a formal notification of the press release, the press release itself contains the substance of Pfizer's performance. Investors seeking to understand Pfizer's trajectory and immediate financial health should consult the provided press release for details on sales, profitability, and any forward-looking statements or strategic updates made by the company.

Key Highlights

  • 1Pfizer Inc. (PFE) filed an 8-K report on April 20, 2004.
  • 2The filing's primary purpose is to announce Pfizer's financial results for the first quarter of 2004.
  • 3A press release containing the Q1 2004 financial results is furnished as Exhibit 99.
  • 4The press release is incorporated by reference into the 8-K filing.
  • 5The report confirms the event date for these results was April 19, 2004.
  • 6No specific financial figures are detailed within the 8-K text itself, as they are contained in the referenced press release.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce and provide investors with Pfizer Inc.'s financial results for the first quarter of 2004. It does this by furnishing a press release detailing these results.

The actual financial results for the first quarter of 2004 are contained within the press release that is attached as Exhibit 99 to this 8-K filing. This press release is incorporated by reference into the report.

No, the text of the 8-K filing itself does not contain specific revenue or earnings numbers. These details are provided in the press release (Exhibit 99) which is referenced by the 8-K.

The press release announcing Pfizer's financial results for the first quarter of 2004 was dated April 20, 2004, and the earliest event reported was also on April 20, 2004.